Galventa Launches Revolutionary Wake-Up Supplement B・SYNC® ON and Expands Partnership with GEN in Turkish Market

May 9, 2023

Galventa, a cutting-edge galenic innovation solutions provider, has unveiled its latest product, B・SYNC® ON, a revolutionary supplement designed to support and enhance the wake-up process. In conjunction with the product launch, we have consolidated our partnership with GEN in the Turkish market, marking a significant milestone in our growth and expansion.

Our journey has been tremendously exciting. From our early days as a small startup to our current position, we have remained committed to delivering innovative solutions that support and enhance the lives of consumers around the world. Over the years, our mission has always been to deliver the best product and provide a positive impact on people’s health and well-being. Today, we are proud of our growth towards leading the science for clinically validated nutrition by engineering cutting-edge galenic formulations that feature best-in-class bioavailability and efficacy for consumers. As we continue to grow and expand our reach, we remain focused on our core values of innovation, excellence, and customer satisfaction, and we look forward to many more years of growth.

The launch of B・SYNC® ON in the Turkish market represents a significant milestone for the company, as it marks its first entry into the region and underscores its commitment to meeting Turkish consumers’ unique needs and preferences. To ensure that the product is widely available to consumers, Galventa has partnered with GEN, who will leverage its expertise and extensive distribution network to expand the reach of the product throughout the region. GEN is the leading specialty pharmaceutical company in Türkiye with more than 25 years of experience. As one of the fastest-growing pharmaceutical companies in Türkiye, GEN offers global solutions to rare diseases and unmet medical needs and is taking bold steps toward its goal of becoming an important global player in the pharmaceutical industry.